$ADMS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adamas Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adamas Pharmaceuticals Inc. Get notifications about new insider transactions in Adamas Pharmaceuticals Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Sell | S | 5.16 | 6,200 | 31,983 | 165,735 | 171.9 K to 165.7 K (-3.61 %) |
| Jun 08 2021 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Sell | S | 5.17 | 2,000 | 10,340 | 8,000 | 10 K to 8 K (-20.00 %) |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | Papapetropoulos Spyridon | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | Papapetropoulos Spyridon | Director | Grant | A | 0.00 | 5,000 | 0 | 20,975 | 16 K to 21 K (+31.30 %) |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Grant | A | 0.00 | 5,000 | 0 | 115,153 | 110.2 K to 115.2 K (+4.54 %) |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 23 2021 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Sell | S | 5.50 | 1,051 | 5,781 | 169,435 | 170.5 K to 169.4 K (-0.62 %) |
| Mar 23 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 5.48 | 2,422 | 13,273 | 145,017 | 147.4 K to 145 K (-1.64 %) |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | M | 0.67 | 48,000 | 31,920 | 0 | |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Buy | M | 0.67 | 48,000 | 31,920 | 110,153 | 62.2 K to 110.2 K (+77.23 %) |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | M | 0.67 | 192,000 | 127,680 | 0 | |
| Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Buy | M | 0.67 | 192,000 | 127,680 | 197,000 | 5 K to 197 K (+3,840.00 %) |
| Mar 15 2021 | ADMS | Adamas Pharmaceuti ... | Papapetropoulos Spyridon | Director | Buy | P | 5.06 | 5,975 | 30,234 | 15,975 | 10 K to 16 K (+59.75 %) |
| Mar 03 2021 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Grant | A | 0.00 | 300,000 | 0 | 525,000 | 225 K to 525 K (+133.33 %) |
| Mar 03 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 147,439 | 72.4 K to 147.4 K (+103.54 %) |
| Feb 01 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 6.36 | 3,821 | 24,302 | 72,439 | 76.3 K to 72.4 K (-5.01 %) |
| Feb 01 2021 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Sell | S | 6.39 | 4,514 | 28,844 | 95,486 | 100 K to 95.5 K (-4.51 %) |
| Jan 22 2021 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 4.41 | 2,630 | 11,598 | 76,260 | 78.9 K to 76.3 K (-3.33 %) |
| Nov 02 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 3.21 | 2,050 | 6,581 | 78,890 | 80.9 K to 78.9 K (-2.53 %) |
| Nov 02 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 3.21 | 2,050 | 6,581 | 78,890 | 80.9 K to 78.9 K (-2.53 %) |
| Sep 01 2020 | ADMS | Adamas Pharmaceuti ... | RICHO ANNA | Director | Option Exercise | A | 5.12 | 20,000 | 102,400 | 20,000 | |
| Sep 01 2020 | ADMS | Adamas Pharmaceuti ... | RICHO ANNA | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Grant | A | 0.00 | 5,000 | 0 | 53,000 | 48 K to 53 K (+10.42 %) |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Grant | A | 0.00 | 5,000 | 0 | 62,153 | 57.2 K to 62.2 K (+8.75 %) |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Mar 20 2020 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Option Exercise | A | 1.99 | 200,000 | 398,000 | 200,000 | |
| Mar 20 2020 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 225,000 | 125 K to 225 K (+80.00 %) |
| Mar 19 2020 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Option Exercise | A | 2.32 | 47,500 | 110,200 | 47,500 | |
| Mar 19 2020 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Grant | A | 0.00 | 23,750 | 0 | 95,000 | 71.3 K to 95 K (+33.33 %) |
| Mar 19 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 80,940 | 70.9 K to 80.9 K (+14.10 %) |
| Jan 23 2020 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Sell | S | 5.92 | 1,269 | 7,512 | 70,940 | 72.2 K to 70.9 K (-1.76 %) |
| Nov 08 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Option Exercise | A | 4.70 | 50,000 | 235,000 | 50,000 | |
| Nov 08 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 72,209 | 47.2 K to 72.2 K (+52.96 %) |
| Sep 23 2019 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Sell | S | 6.91 | 1,584 | 10,945 | 48,019 | 49.6 K to 48 K (-3.19 %) |
| Sep 18 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | M | 1.76 | 33,332 | 58,498 | 0 | |
| Sep 18 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | M | 1.76 | 33,332 | 58,498 | 0 | |
| Sep 18 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Buy | M | 1.76 | 33,332 | 58,498 | 57,153 | 23.8 K to 57.2 K (+139.93 %) |
| Sep 18 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Buy | M | 1.76 | 33,332 | 58,498 | 57,153 | 23.8 K to 57.2 K (+139.93 %) |
| Sep 17 2019 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Option Exercise | A | 6.25 | 250,000 | 1,562,500 | 250,000 | |
| Sep 17 2019 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
| Sep 13 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 6.08 | 40,000 | 243,200 | 40,000 | |
| Sep 13 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 6.08 | 40,000 | 243,200 | 40,000 | |
| Jul 23 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 6.00 | 1,082 | 6,492 | 47,209 | 48.3 K to 47.2 K (-2.24 %) |
| Jun 21 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 5.35 | 940 | 5,029 | 63,114 | 64.1 K to 63.1 K (-1.47 %) |
| Jun 07 2019 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Option Exercise | A | 4.67 | 137,500 | 642,125 | 137,500 | |
| Jun 07 2019 | ADMS | Adamas Pharmaceuti ... | Shreedhar Vijay | Chief Commercial Of ... | Grant | A | 0.00 | 68,750 | 0 | 68,750 | 0 to 68.8 K |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | A | 6.81 | 112,500 | 766,125 | 112,500 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Grant | A | 0.00 | 56,250 | 0 | 232,541 | 176.3 K to 232.5 K (+31.91 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 6.81 | 60,000 | 408,600 | 60,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 30,000 | 0 | 61,612 | 31.6 K to 61.6 K (+94.90 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Option Exercise | A | 6.81 | 37,500 | 255,375 | 37,500 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 18,750 | 0 | 48,291 | 29.5 K to 48.3 K (+63.47 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 6.81 | 60,000 | 408,600 | 60,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 0.00 | 30,000 | 0 | 49,141 | 19.1 K to 49.1 K (+156.73 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Option Exercise | A | 6.81 | 50,000 | 340,500 | 50,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 49,603 | 24.6 K to 49.6 K (+101.61 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Sell | S | 7.99 | 857 | 6,847 | 24,603 | 25.5 K to 24.6 K (-3.37 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 8.00 | 2,374 | 18,992 | 19,141 | 21.5 K to 19.1 K (-11.03 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 8.00 | 1,185 | 9,480 | 29,541 | 30.7 K to 29.5 K (-3.86 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 7.99 | 1,792 | 14,318 | 31,612 | 33.4 K to 31.6 K (-5.36 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 7.99 | 6,319 | 50,489 | 176,291 | 182.6 K to 176.3 K (-3.46 %) |
| Dec 28 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 12,500 | 0 | 30,726 | 18.2 K to 30.7 K (+68.58 %) |
| Dec 26 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 7.51 | 228 | 1,712 | 18,226 | 18.5 K to 18.2 K (-1.24 %) |
| Dec 21 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 7.52 | 425 | 3,196 | 33,404 | 33.8 K to 33.4 K (-1.26 %) |
| Nov 08 2018 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Buy | P | 12.98 | 3,850 | 49,956 | 199,242 | 195.4 K to 199.2 K (+1.97 %) |
| Sep 21 2018 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Sell | S | 19.18 | 1,665 | 31,935 | 25,460 | 27.1 K to 25.5 K (-6.14 %) |
| Jun 22 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 25.48 | 1,002 | 25,531 | 33,794 | 34.8 K to 33.8 K (-2.88 %) |
| Jun 22 2018 | ADMS | Adamas Pharmaceuti ... | KING RICHARD | Chief Operating Off ... | Sell | S | 25.48 | 2,501 | 63,725 | 48,856 | 51.4 K to 48.9 K (-4.87 %) |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 25.75 | 4,541 | 116,931 | 182,610 | 187.2 K to 182.6 K (-2.43 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 25.89 | 982 | 25,424 | 34,128 | 35.1 K to 34.1 K (-2.80 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Sell | S | 25.98 | 567 | 14,731 | 17,758 | 18.3 K to 17.8 K (-3.09 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 25.94 | 1,252 | 32,477 | 21,515 | 22.8 K to 21.5 K (-5.50 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 25.94 | 1,252 | 32,477 | 21,515 | 22.8 K to 21.5 K (-5.50 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Option Exercise | A | 25.66 | 30,000 | 769,800 | 30,000 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 5,000 | 0 | 18,325 | 13.3 K to 18.3 K (+37.52 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 25.66 | 54,750 | 1,404,885 | 54,750 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 0.00 | 9,125 | 0 | 22,767 | 13.6 K to 22.8 K (+66.89 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Option Exercise | A | 25.66 | 50,250 | 1,289,415 | 50,250 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Grant | A | 0.00 | 8,375 | 0 | 27,125 | 18.8 K to 27.1 K (+44.67 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | KING RICHARD | Chief Operating Off ... | Option Exercise | A | 25.66 | 66,000 | 1,693,560 | 66,000 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | KING RICHARD | Chief Operating Off ... | Grant | A | 0.00 | 11,000 | 0 | 50,661 | 39.7 K to 50.7 K (+27.74 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | A | 25.66 | 123,750 | 3,175,425 | 123,750 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Grant | A | 0.00 | 20,625 | 0 | 187,151 | 166.5 K to 187.2 K (+12.39 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 25.66 | 37,500 | 962,250 | 37,500 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 6,250 | 0 | 35,110 | 28.9 K to 35.1 K (+21.66 %) |
| Mar 01 2018 | ADMS | Adamas Pharmaceuti ... | KING RICHARD | Chief Operating Off ... | Grant | A | 25.07 | 10,000 | 250,700 | 39,661 | 29.7 K to 39.7 K (+33.71 %) |
| Dec 21 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 32.30 | 440 | 14,212 | 28,860 | 29.3 K to 28.9 K (-1.50 %) |
| Nov 30 2017 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 35.12 | 10,000 | 351,200 | 10,000 | |
| Oct 11 2017 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 21.69 | 30,000 | 650,700 | 30,000 | |
| Oct 10 2017 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Option Exercise | A | 23.11 | 15,000 | 346,650 | 15,000 | |
| Oct 10 2017 | ADMS | Adamas Pharmaceuti ... | Prentiss Christopher B | Chief Accounting Of ... | Grant | A | 0.00 | 2,500 | 0 | 12,405 | 9.9 K to 12.4 K (+25.24 %) |
| Jul 10 2017 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Option Exercise | A | 16.98 | 112,500 | 1,910,250 | 112,500 | |
| Jul 10 2017 | ADMS | Adamas Pharmaceuti ... | MERRIWEATHER ALFRED G | Chief Financial Off ... | Grant | A | 0.00 | 18,750 | 0 | 18,750 | 0 to 18.8 K |
| Jun 22 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 17.53 | 1,041 | 18,254 | 28,455 | 29.5 K to 28.5 K (-3.53 %) |
| Jun 21 2017 | ADMS | Adamas Pharmaceuti ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 17.44 | 10,000 | 174,365 | 2,216,351 | 2.2 M to 2.2 M (-0.45 %) |
| Jun 21 2017 | ADMS | Adamas Pharmaceuti ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 17.35 | 20,000 | 346,934 | 2,231,351 | 2.3 M to 2.2 M (-0.89 %) |
| Jun 21 2017 | ADMS | Adamas Pharmaceuti ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 17.05 | 350,000 | 5,967,675 | 2,251,351 | 2.6 M to 2.3 M (-13.45 %) |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | Ericson William W. | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | MAHONEY DAVID L | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | LIEBERBURG IVAN M | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | DEMSKI MARTHA J | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| May 05 2017 | ADMS | Adamas Pharmaceuti ... | KING RICHARD | Chief Operating Off ... | Option Exercise | A | 17.40 | 168,750 | 2,936,250 | 168,750 | |
| May 05 2017 | ADMS | Adamas Pharmaceuti ... | KING RICHARD | Chief Operating Off ... | Grant | A | 0.00 | 28,125 | 0 | 28,125 | 0 to 28.1 K |
| Mar 22 2017 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | S | 17.03 | 2,807 | 47,803 | 166,526 | 169.3 K to 166.5 K (-1.66 %) |
| Mar 22 2017 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Sell | S | 17.04 | 733 | 12,490 | 13,642 | 14.4 K to 13.6 K (-5.10 %) |
| Mar 22 2017 | ADMS | Adamas Pharmaceuti ... | DAWSON WILLIAM J | Chief Financial Off ... | Sell | S | 17.02 | 716 | 12,186 | 14,284 | 15 K to 14.3 K (-4.77 %) |
| Feb 23 2017 | ADMS | Adamas Pharmaceuti ... | DAWSON WILLIAM J | Chief Financial Off ... | Option Exercise | A | 17.20 | 45,000 | 774,000 | 45,000 | |
| Feb 23 2017 | ADMS | Adamas Pharmaceuti ... | DAWSON WILLIAM J | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 15,000 | 7.5 K to 15 K (+100.00 %) |
| Feb 23 2017 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | A | 17.20 | 138,750 | 2,386,500 | 138,750 | |
| Feb 23 2017 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Grant | A | 0.00 | 23,125 | 0 | 169,333 | 146.2 K to 169.3 K (+15.82 %) |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 16.61 | 67,500 | 1,121,175 | 67,500 | |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 11,250 | 0 | 27,187 | 15.9 K to 27.2 K (+70.59 %) |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Option Exercise | A | 16.61 | 41,250 | 685,163 | 41,250 | |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Patni Rajiv | Chief Medical Offic ... | Grant | A | 0.00 | 6,875 | 0 | 14,375 | 7.5 K to 14.4 K (+91.67 %) |
| Nov 08 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Option Exercise | A | 14.26 | 28,125 | 401,063 | 28,125 | |
| Nov 08 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Grant | A | 0.00 | 4,687 | 0 | 15,937 | 11.3 K to 15.9 K (+41.66 %) |
| Oct 07 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | J | 17.31 | 9,439 | 163,389 | 65,561 | |
| Oct 07 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | J | 9.00 | 262,963 | 2,365,352 | 605,037 | |
| Oct 07 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | J | 0.67 | 27,995 | 18,617 | 32,005 | |
| Oct 07 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Option Exercise | J | 0.67 | 121,784 | 80,986 | 128,216 | |
| Oct 07 2016 | ADMS | Adamas Pharmaceuti ... | Went Gregory T | Chief Executive Off ... | Sell | J | 0.00 | 195,400 | 0 | 195,392 | 390.8 K to 195.4 K (-50.00 %) |